BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35388566)

  • 1. Methylation classifiers: Brain tumors, sarcomas, and what's next.
    Koelsche C; von Deimling A
    Genes Chromosomes Cancer; 2022 Jun; 61(6):346-355. PubMed ID: 35388566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'.
    Lyskjaer I; De Noon S; Tirabosco R; Rocha AM; Lindsay D; Amary F; Ye H; Schrimpf D; Stichel D; Sill M; Koelsche C; Pillay N; Von Deimling A; Beck S; Flanagan AM
    J Pathol Clin Res; 2021 Jul; 7(4):350-360. PubMed ID: 33949149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcoma classification by DNA methylation profiling.
    Koelsche C; Schrimpf D; Stichel D; Sill M; Sahm F; Reuss DE; Blattner M; Worst B; Heilig CE; Beck K; Horak P; Kreutzfeldt S; Paff E; Stark S; Johann P; Selt F; Ecker J; Sturm D; Pajtler KW; Reinhardt A; Wefers AK; Sievers P; Ebrahimi A; Suwala A; Fernández-Klett F; Casalini B; Korshunov A; Hovestadt V; Kommoss FKF; Kriegsmann M; Schick M; Bewerunge-Hudler M; Milde T; Witt O; Kulozik AE; Kool M; Romero-Pérez L; Grünewald TGP; Kirchner T; Wick W; Platten M; Unterberg A; Uhl M; Abdollahi A; Debus J; Lehner B; Thomas C; Hasselblatt M; Paulus W; Hartmann C; Staszewski O; Prinz M; Hench J; Frank S; Versleijen-Jonkers YMH; Weidema ME; Mentzel T; Griewank K; de Álava E; Martín JD; Gastearena MAI; Chang KT; Low SYY; Cuevas-Bourdier A; Mittelbronn M; Mynarek M; Rutkowski S; Schüller U; Mautner VF; Schittenhelm J; Serrano J; Snuderl M; Büttner R; Klingebiel T; Buslei R; Gessler M; Wesseling P; Dinjens WNM; Brandner S; Jaunmuktane Z; Lyskjær I; Schirmacher P; Stenzinger A; Brors B; Glimm H; Heining C; Tirado OM; Sáinz-Jaspeado M; Mora J; Alonso J; Del Muro XG; Moran S; Esteller M; Benhamida JK; Ladanyi M; Wardelmann E; Antonescu C; Flanagan A; Dirksen U; Hohenberger P; Baumhoer D; Hartmann W; Vokuhl C; Flucke U; Petersen I; Mechtersheimer G; Capper D; Jones DTW; Fröhling S; Pfister SM; von Deimling A
    Nat Commun; 2021 Jan; 12(1):498. PubMed ID: 33479225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience.
    Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D
    Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in sarcoma molecular diagnostics.
    Wang XQ; Goytain A; Dickson BC; Nielsen TO
    Genes Chromosomes Cancer; 2022 Jun; 61(6):332-345. PubMed ID: 35064596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular tumor classification using DNA methylome analysis.
    Sill M; Plass C; Pfister SM; Lipka DB
    Hum Mol Genet; 2020 Oct; 29(R2):R205-R213. PubMed ID: 32657331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain Tumor Classification by Methylation Profile.
    Park JW; Lee K; Kim EE; Kim SI; Park SH
    J Korean Med Sci; 2023 Nov; 38(43):e356. PubMed ID: 37935168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
    Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
    Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences from tissue microarray in soft tissue sarcomas.
    Nilbert M; Engellau J
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):29-34. PubMed ID: 15188663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors].
    Bertram S; Schildhaus HU
    Pathologe; 2020 Nov; 41(6):589-605. PubMed ID: 32965532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.
    Renner M; Wolf T; Meyer H; Hartmann W; Penzel R; Ulrich A; Lehner B; Hovestadt V; Czwan E; Egerer G; Schmitt T; Alldinger I; Renker EK; Ehemann V; Eils R; Wardelmann E; Büttner R; Lichter P; Brors B; Schirmacher P; Mechtersheimer G
    Genome Biol; 2013 Dec; 14(12):r137. PubMed ID: 24345474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
    Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre.
    Jaunmuktane Z; Capper D; Jones DTW; Schrimpf D; Sill M; Dutt M; Suraweera N; Pfister SM; von Deimling A; Brandner S
    Acta Neuropathol Commun; 2019 Feb; 7(1):24. PubMed ID: 30786920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic profiling for the molecular classification of metastatic brain tumors.
    Orozco JIJ; Knijnenburg TA; Manughian-Peter AO; Salomon MP; Barkhoudarian G; Jalas JR; Wilmott JS; Hothi P; Wang X; Takasumi Y; Buckland ME; Thompson JF; Long GV; Cobbs CS; Shmulevich I; Kelly DF; Scolyer RA; Hoon DSB; Marzese DM
    Nat Commun; 2018 Nov; 9(1):4627. PubMed ID: 30401823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of DNA methylation assessment in the morphological diagnosis of brain tumours].
    Ryzhova MV; Galstyan SA; Telysheva EN
    Arkh Patol; 2022; 84(3):65-75. PubMed ID: 35639846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Sarcoma Diagnosis, Genetics, and Genomics.
    Schaefer IM; Cote GM; Hornick JL
    J Clin Oncol; 2018 Jan; 36(2):101-110. PubMed ID: 29220288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of DNA methylation profiling in neuro-oncology as a diagnostic support tool: A review.
    Singh J; Sahu S; Mohan T; Mahajan S; Sharma MC; Sarkar C; Suri V
    Neurooncol Pract; 2023 Dec; 10(6):518-526. PubMed ID: 38009119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of the methylation specific PCR technical conditions for the detection of p16 promoter hypermethylation in small amounts of tumor DNA.
    Fan X; Inda MM; Tunon T; Castresana JS
    Oncol Rep; 2002; 9(1):181-3. PubMed ID: 11748479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
    Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H
    Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.